Event Type: The Company will be attending an Investor Conference involving Group and 1x1 Meetings.
Date and Time: The meetings are scheduled for November 16, 2026, starting at 11:00 AM IST onwards.
Organizer: The conference is organized by Avendus Spark.
Location: The meetings will take place in Mumbai.
Purpose: The stated purpose is for analyst and institutional investor meetings. Discussions will be based on publicly available information.
UPSI Statement: The company has explicitly stated that "No unpublished price sensitive information (UPSI) will be discussed during the said Meetings."
Management Participants: The disclosure mentions that "Officials of the Company" will be attending, but no specific names or designations are provided.
Presentation Availability: No mention is made of any presentation, earnings deck, transcript, or recording being made available.
Additional Notes Section
Regulatory Compliance: This intimation is made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Website Disclosure: The intimation is also available on the company's website at www.coronaremedies.com.
Contingency Note: The disclosure notes that "changes in the above schedule may happen due to exigencies on the part of Host / Company."
Financial Data: No financial data, guidance references, or presentation summaries were disclosed in this announcement.
Attachments: No attachments were mentioned in the disclosure.